These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18539908)

  • 1. Antibiotics in 30 minutes or less for febrile neutropenic patients: a quality control measure in a new hospital.
    Corey AL; Snyder S
    J Pediatr Oncol Nurs; 2008; 25(4):208-12. PubMed ID: 18539908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy.
    Baltic T; Schlosser E; Bedell MK
    Clin J Oncol Nurs; 2002; 6(6):337-40. PubMed ID: 12434465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of fever in neutropenic patients with different risks of complications.
    Klastersky J
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments.
    Rolston KV
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S44-8. PubMed ID: 15250020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
    Tam CS; O'Reilly M; Andresen D; Lingaratnam S; Kelly A; Burbury K; Turnidge J; Slavin MA; Worth LJ; Dawson L; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):90-101. PubMed ID: 21272173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
    Sipsas NV; Bodey GP; Kontoyiannis DP
    Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the febrile neutropenic patient: a consensus conference.
    Picazo JJ
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S1-6. PubMed ID: 15250013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic procedures and management of Fever in pediatric cancer patients].
    Laws HJ; Ammann RA; Lehrnbecher T
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S9-16. PubMed ID: 16288350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission and care of the febrile neutropenic patient in a community hospital setting.
    Ford MS; Helsley M
    J Support Oncol; 2005; 3(6 Suppl 4):22-3. PubMed ID: 16355555
    [No Abstract]   [Full Text] [Related]  

  • 12. Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.
    Volpe D; Harrison S; Damian F; Rachh P; Kahlon PS; Morrissey L; Mack J; Akenroye A; Stack AM
    Pediatrics; 2012 Jul; 130(1):e201-10. PubMed ID: 22711718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutropenic fever and sepsis: evaluation and management.
    Rolston KV
    Cancer Treat Res; 2014; 161():181-202. PubMed ID: 24706225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.
    Ramphal R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S25-31. PubMed ID: 15250017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic approach to a patient with febrile neutropenia].
    Duraković N; Nemet D
    Lijec Vjesn; 2007; 129(10-11):344-50. PubMed ID: 18257335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a quality improvement intervention to decrease delays in antibiotic delivery in pediatric febrile neutropenia: a pilot study.
    Amado VM; Vilela GP; Queiroz A; Amaral AC
    J Crit Care; 2011 Feb; 26(1):103.e9-12. PubMed ID: 20619598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.
    Masaoka T
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S49-52. PubMed ID: 15250021
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of educational and infrastructural barriers to prompt antibiotic delivery in febrile neutropenia: a quality improvement initiative.
    Burry E; Punnett A; Mehta A; Thull-Freedman J; Robinson L; Gupta S
    Pediatr Blood Cancer; 2012 Sep; 59(3):431-5. PubMed ID: 22147665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
    Sepkowitz KA
    Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.